Genmab A/s
(NASDAQ) GMAB
Genmab A/s Financials at a Glance
Market Cap
$14.72B
Revenue (TTM)
$3.90B
Net Income (TTM)
$821.03M
EPS (TTM)
$1.33
P/E Ratio
18.48
Dividend
$0.00
Beta (Volatility)
0.72 (Low)
Dividend
$0.00
Beta (Volatility)
0.72 (Low)
Price
$24.76
Volume
2,191,662
Open
$24.48
Price
$24.76
Volume
2,191,662
Open
$24.48
Previous Close
$24.74
Daily Range
$24.09 - $24.78
52-Week Range
$20.23 - $35.43
Estimated Earnings Date
Aug 6, 2026
Dividend
$0.00
Beta (Volatility)
0.72 (Low)
Price
$24.76
Volume
2,191,662
Open
$24.48
Previous Close
$24.74
Daily Range
$24.09 - $24.78
52-Week Range
$20.23 - $35.43
Estimated Earnings Date
Aug 6, 2026
GMAB News
GMAB: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Genmab A/s
Industry
Biotechnology
Sector
Health CareEmployees
3,088
CEO
Jan G. J. van de Winkel, PhD
Website
www.genmab.comHeadquarters
Copenhagen, 1560, DK
GMAB Financials
Key Financial Metrics (TTM)
Gross Margin
39%
Operating Margin
14%
Net Income Margin
9%
Return on Equity
15%
Return on Capital
11%
Return on Assets
7%
Earnings Yield
5.41%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$14.72B
Shares Outstanding
594.91M
Volume
2.19M
Avg. Volume
1.81M
Financials (TTM)
Gross Profit
$3.41B
Operating Income
$1.25B
EBITDA
$1.34B
Operating Cash Flow
$1.19B
Capital Expenditure
-$37.03M
Free Cash Flow
$1.15B
Cash & ST Invst.
$1.71B
Total Debt
$5.43B
Genmab A/s Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$899.32M
+754.6%
Gross Profit
$834.08M
+742.1%
Gross Margin
92.75%
N/A
Market Cap
$14.72B
N/A
Market Cap/Employee
$5.58M
N/A
Employees
2,638
N/A
Net Income
$53.20M
+85.4%
EBITDA
$186.69M
+378.7%
Quarterly Fundamentals
Total Cash
$1.52B
-43.7%
Total Debt
$5.35B
+3776.4%
Accounts Receivable
$1.03B
+10.8%
Inventory
$21.00M
+73.2%
Long Term Debt
$5.06B
+4008.3%
Short Term Debt
$311.00M
+1984.0%
Return on Assets
6.63%
N/A
Return on Invested Capital
11.49%
N/A
Free Cash Flow
-$2.01M
-100.8%
Operating Cash Flow
$3.01M
-99.0%